COSM Stock Overview
Cosmos Health Inc. ofrece una línea patentada de productos farmacéuticos de marca y genéricos, nutracéuticos, medicamentos de venta libre, cosméticos, productos de puericultura, sanitarios y para bebés, y dispositivos médicos.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Cosmos Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.70 |
| 52 Week High | US$4.05 |
| 52 Week Low | US$0.61 |
| Beta | 2.85 |
| 1 Month Change | -8.92% |
| 3 Month Change | -45.49% |
| 1 Year Change | -78.66% |
| 3 Year Change | -99.51% |
| 5 Year Change | -99.19% |
| Change since IPO | -99.56% |
Recent News & Updates
Recent updates
Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch
Feb 23
Cosmos Holdings intends to acquire telemedicine platform ZipDoctor
Sep 28Cosmos Holdings reports Q2 results
Aug 22Cosmos changes name to Cosmos Healthto
Jul 29Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically
Jul 20Cosmos Holdings to acquire bone health product portfolio from LIFE NLB
Jul 06Shareholder Returns
| COSM | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -0.3% | -4.8% | -0.7% |
| 1Y | -78.7% | -2.7% | 25.9% |
Rentabilidad frente al sector: COSM obtuvo unos resultados inferiores a los del sector US Healthcare , que el año pasado arrojó un rendimiento del -4.6%.
Rentabilidad vs. Mercado: COSM obtuvo unos resultados inferiores a los del mercado US, que fue del 14.1% el año pasado.
Price Volatility
| COSM volatility | |
|---|---|
| COSM Average Weekly Movement | 9.5% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: COSMha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de COSM (10%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 102 | Greg Siokas | https://www.cosmosholdingsinc.com |
Cosmos Health Inc. ofrece una línea propia de productos farmacéuticos de marca y genéricos, nutracéuticos, medicamentos de venta libre, cosméticos, productos de puericultura, para el cuidado de la salud y del bebé, y dispositivos médicos. Su cartera de productos nutracéuticos incluye Sky Premium Life y Mediterranation. La empresa abastece a distribuidores farmacéuticos mayoristas y farmacias minoristas independientes.
Cosmos Health Inc. Fundamentals Summary
| COSM fundamental statistics | |
|---|---|
| Market cap | US$11.67m |
| Earnings (TTM) | -US$42.91m |
| Revenue (TTM) | US$49.59m |
0.2x
P/S Ratio-0.3x
P/E RatioIs COSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COSM income statement (TTM) | |
|---|---|
| Revenue | US$49.59m |
| Cost of Revenue | US$46.03m |
| Gross Profit | US$3.55m |
| Other Expenses | US$46.46m |
| Earnings | -US$42.91m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.55 |
| Gross Margin | 7.17% |
| Net Profit Margin | -86.53% |
| Debt/Equity Ratio | 21.5% |
How did COSM perform over the long term?
See historical performance and comparison